INS and gastrointestinal disease: Exclusion criteria included daily use of premixed insulin, transition to insulin pump therapy in the last three months, real-time continuous glucose monitoring use in the last three months, participation in another intervention study in the last six months, and presence of gastrointestinal disease such as celiac disease, multiple food allergies, use of medications that interfere significantly with glucose metabolism, or significant mental illness.